DCM
REGN icon

Driehaus Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Driehaus Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,552
Closed -$5.8M – 601
2014
Q2 		$5.8M Buy
+20,552
New +$6.09M 0.19% 145

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Driehaus Capital Management's REGN Position: Q3 2014 in Review

Driehaus Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2014, closing a stake of 20,552 shares — an estimated $5.8M sold.

Driehaus Capital Management first reported a position in REGN in Q2 2014 and held it in 1 quarter. The position peaked at $5.8M in Q2 2014. 473 funds tracked by Wall St. Rank hold REGN as of Q3 2014.

  • Driehaus Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Driehaus Capital Management sold 20,552 Regeneron Pharmaceuticals shares in Q3 2014, an estimated $5.8M.
  • Driehaus Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Regeneron Pharmaceuticals position peaked at $5.8M in Q2 2014.
  • 473 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2014.

Based on Driehaus Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.